New York--Men with prostate cancer are being urged to seek the advice of a medical oncologist in a new educational campaign launched by the Prostate Cancer Foundation.
Andrew Bowser
Advertisement
Articles by Andrew Bowser
Orlando, FL-In patients with metastatic renal cell carcinoma, adjuvant interleukin-2 (IL-2) after cytoreductive nephrectomy appears to offer a superior survival benefit over nephrectomy followed by interferon alpha-2b, according to a report presented here at the American Society of Clinical Oncology annual meeting.
Advertisement
Latest Updated Articles
- Prostate Ca patients urged to consult a medical oncologist
Published: November 1st 2004 | Updated:
- Adjuvant IL-2 offers survival benefit in metastatic RCC
Published: September 1st 2002 | Updated:
Advertisement
Advertisement
Trending on Urology Times
1
Gemcitabine intravesical system delivers high 12-month DFS in papillary-only NMIBC
2
NDV-01 produces robust 9-month results in high-risk NMIBC
3
Choosing salvage therapy after prostate cancer focal ablation
4
SYNC-T demonstrates high bone metastasis resolution in phase 1 cohort
5
